跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CIPLA BECLOMETASONE/FORMOTEROL 100/6 beclometasone dipropionate 100 mcg formoterol fumarate dihydrate 6 mcg pressurised inhalation aerosol can - TGA Drug Approval Details
Approvals
/
TGA
/
CIPLA BECLOMETASONE/FORMOTEROL 100/6 beclometasone dipropionate 100 mcg formoterol fumarate dihydrate 6 mcg pressurised inhalation aerosol can
Approved
STANDARD
CIPLA BECLOMETASONE/FORMOTEROL 100/6 beclometasone dipropionate 100 mcg formoterol fumarate dihydrate 6 mcg pressurised inhalation aerosol can
Cipla Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
ea75674112eaaa21
Company
Cipla Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
ea75674112eaaa21
Product Name
CIPLA BECLOMETASONE/FORMOTEROL 100/6 beclometasone dipropionate 100 mcg formoterol fumarate dihydrate 6 mcg pressurised inhalation aerosol can
Artg Id
408415
Artg Name
CIPLA BECLOMETASONE/FORMOTEROL 100/6 beclometasone dipropionate 100 mcg formoterol fumarate dihydrate 6 mcg pressurised inhalation aerosol can
Sponsor
Cipla Australia Pty Ltd
Company Detail Path
/organization/cipla-australia-pty-ltd
Artg Date
2025-03-24
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
ea75674112eaaa21
Type
Standard
Back to TGA Approvals